BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 12-Dec-2019

(Continuation news of SQURPHARMA): the separated operations of various aspects of SFRL is a complex one. Since SPL holds 99.50% of the Paid up Capital of SFRL with only 0.50% being held by the minority shareholders, Board of Directors have recommended for amalgamation under provision of section 228 and 229 of the Companies Act 1994. Reason of merger between Square Herbal and Nutraceuticals Ltd. and Square Pharmaceuticals Ltd. is to reform Square Pharmaceuticals Ltd; (cont. 3)

SQURPHARMA 12-Dec-2019

Emphasis of Matter: We draw attention to Note 1.28 of the separate ?nancial statements which describe the amalgamation of the fully owned subsidiary the Square Formulations Ltd. and the Square Herbal and Nutraceuticals Ltd. with the Company. The Board of Directors of the Company in its meeting held on 16th October 2017 approved the amalgamation of the Company with the Subsidiaries (cont. 1)

SQURPHARMA 12-Dec-2019

(Continuation news of SQURPHARMA): into a diversi?ed high performance and value added company, Board of Directors considered a proposal for amalgation of Square Herbal and Nutraceuticals Ltd. with Square Pharmaceuticals Ltd. under provision of section 228 and 229 of the Companies Act 1994. The Process of Merger: After approval of Board of Directors and consent of minority shareholders, the Hon'ble High Court Division of the Supreme Court of Bangladesh has sanctioned (cont. 4)

SQURPHARMA 07-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2019 at 3.00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

SQURPHARMA 23-Oct-2019

The Board of Directors has recommended 42% cash and 7% stock dividend for the year ended on June 30, 2019. The Board has also approved Tk. 200.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 12.12.2019, Time: 10:00 AM, Venue: Samson H Chowdhury Centre Dhaka Club Ltd., Ramna, Dhaka. Record Date: 19.11.2019. (cont.1)

SQURPHARMA 10-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 22, 2019 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

SQURPHARMA 23-Apr-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2019 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

SQURPHARMA 24-Jan-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2019 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2018.

SQURPHARMA 07-Nov-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2018 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

SQURPHARMA 22-Oct-2018

The Board of Directors has recommended 36% cash and 7% stock dividend for the year ended on June 30, 2018. The Board has also approved Tk. 200.00 crore for BMRE, Capital Machinery and Lands for future expansion. Date of AGM: 20.12.2018, Time: 10:00 AM, Venue: Samson H Chowdhury Centre Dhaka Club Ltd., Ramna, Dhaka. Record Date: 27.11.2018. (cont.)

Previous Next page